Martin Hubbes

Martin Hubbes

Director/Board Member chez H-SOURCE HOLDINGS LTD.

61 ans
Finance
Consumer Services
Commercial Services

Profil

Martin Hubbes is currently the Chief Investment Officer & Director at H-Source, Inc. and a Director at Ciclofilin Pharmaceuticals, Inc. He is also an Independent Director at H-Source Holdings Ltd.
and a Member of CFA Society Toronto.
Previously, he served as an Independent Director at EcoSynthetix, Inc. from 2017 to 2021.
He was also the Managing Director at Agf Management Deutschland GmbH from 1993 to 1995 and the Chief Investment Officer at AGF Investments, Inc. He served as the Chief Investment Officer & Executive VP at AGF Investments America, Inc. from 2005 to 2014.
Mr. Hubbes has an undergraduate and graduate degree from the University of Toronto and an MBA from The Schulich School of Business.

Postes actifs de Martin Hubbes

SociétésPosteDébut
H-SOURCE HOLDINGS LTD. Director/Board Member 30/09/2016
Corporate Officer/Principal 20/08/2009
Director/Board Member -
Chief Investment Officer -
Tous les postes actifs de Martin Hubbes

Anciens postes connus de Martin Hubbes

SociétésPosteFin
ECOSYNTHETIX INC. Director/Board Member 25/05/2021
Agf Management Deutschland GmbH Chief Executive Officer 01/01/1995
Chief Investment Officer 01/02/2014
Chief Investment Officer -
Voir l'expérience en détail de Martin Hubbes

Formation de Martin Hubbes

University of Toronto Graduate Degree
The Schulich School of Business Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Martin Hubbes

Relations

87

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ECOSYNTHETIX INC.

Process Industries

H-SOURCE HOLDINGS LTD.

Commercial Services

Entreprise privées6

Finance

Health Technology

Finance

Commercial Services

Finance

Agf Management Deutschland GmbH

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Martin Hubbes